Welt Bio-Molecular Pharmaceutical, LLC

Armonk, NY Doing business as Welt Bio-Molecular Pharmaceutical LLC

UEI
Q9NEYZLBH5G3
CAGE
502Z1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
59 Whippoorwill Crossing, Armonk, NY 10504, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Welt Bio-Molecular Pharmaceutical, LLC's 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir phase i: generation of directly active monoclonal antibodies to CD19 for the treatment of b-cell malignancies… Grant · 2212682 National Science Foundation $256,000
Targeting the b-cell recptor complex and downstreatm kinases Grant · R43AI081332 National Institutes of Health $127,330

Quick answers

What is Welt Bio-Molecular Pharmaceutical, LLC's UEI?

Welt Bio-Molecular Pharmaceutical, LLC's Unique Entity ID (UEI) in SAM.gov is Q9NEYZLBH5G3.

What is Welt Bio-Molecular Pharmaceutical, LLC's CAGE code?

Welt Bio-Molecular Pharmaceutical, LLC's CAGE code is 502Z1.

What is Welt Bio-Molecular Pharmaceutical, LLC's primary NAICS code?

Welt Bio-Molecular Pharmaceutical, LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Welt Bio-Molecular Pharmaceutical, LLC located?

Welt Bio-Molecular Pharmaceutical, LLC's physical address in SAM.gov is 59 Whippoorwill Crossing, Armonk, NY 10504, USA.

Is Welt Bio-Molecular Pharmaceutical, LLC registered in SAM.gov?

Yes. Welt Bio-Molecular Pharmaceutical, LLC's SAM.gov registration is active through April 16, 2027.

What is Welt Bio-Molecular Pharmaceutical, LLC's most recent federal award?

Welt Bio-Molecular Pharmaceutical, LLC's most recent federal grant award is Sbir phase i: generation of directly active monoclonal antibodies to CD19 for the treatment of b-cell malignancies… (2212682), from National Science Foundation, on February 1, 2023.

On GovTribe

See Welt Bio-Molecular Pharmaceutical, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login